I den yderligere undersøgelse havde over halvdelen af de patienter, som ikke kunne behandles med deferoxamin, responderet på behandlingen med Exjade efter et år, herunder patienterne på mellem to og fem år.
In the additional study, more than half of the patients who could not be treated with deferoxamine had responded to treatment with Exjade after a year, including patients aged between two and five years.